Skip to content

Tony P. George

4 papers in the library · publishing 2017-2026

Papers

Sort Most recent Most cited

PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence.

Neuropsychopharmacology May 9, 2026 Claudia Poluga, S. S. Dheda, Nadia Boachie et al.

Cannabis withdrawal in cannabis use disorder (CUD) increase the risk of relapse and lacks effective treatments. The endocannabinoid enzyme fatty acid amide hydrolase (FAAH) may influence cannabis use and withdrawal, but the relationship between FAAH levels and withdrawal symptoms remains unclear. This study aims to investigate changes in FAAH levels during short-term abstinence from cannabis...

Cannabis self-administration in the human laboratory: a scoping review of ad libitum studies.

Psychopharmacology July 1, 2023 Ke Bin Xiao, Erin Grennell, Anthony Ngoy et al.

Cannabis self-administration studies may be helpful for identifying factors that influence cannabis consumption and subjective response to cannabis. Additionally, these paradigms could be useful for testing novel pharmacotherapies for cannabis use disorder. This scoping review aims to summarize the findings from existing ad libitum cannabis self-administration studies to determine what has been...

DOI: 10.1007/s00213-023-06360-4 (opens in new tab) Full text (opens in new tab) Ad libitum Cannabis smoking Free-access Human laboratory +2

Combined effect of alcohol and cannabis on simulated driving.

Psychopharmacology May 2022 Andrew Fares, Christine M Wickens, Robert E Mann et al.

With alcohol and cannabis remaining the most commonly detected drugs in seriously and fatally injured drivers, there is a need to understand their combined effects on driving. The present study examined the effects of combinations of smoked cannabis (12.5% THC) and alcohol (target BrAC 0.08%) on simulated driving performance, subjective drug effects, cardiovascular measures, and self-reported...

Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia vs Non-Psychiatric Controls.

Neuropsychopharmacology October 2017 Rachel A Rabin, Mera S Barr, Michelle S Goodman et al.

Cross-sectional studies of the effects of cannabis on cognition in schizophrenia have produced mixed results. Heavy and persistent cannabis use in schizophrenia is a common clinical problem, and effects of controlled abstinence from cannabis in these patients have not been carefully evaluated. The present study sought to determine the effects of cannabis abstinence on cognition in patients with...